SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.

Keller, MF; Saad, M; Bras, J; Bettella, F; Nicolaou, N; Simón-Sánchez, J; Mittag, F; Büchel, F; Sharma, M; Gibbs, JR; et al. Keller, MF; Saad, M; Bras, J; Bettella, F; Nicolaou, N; Simón-Sánchez, J; Mittag, F; Büchel, F; Sharma, M; Gibbs, JR; Schulte, C; Moskvina, V; Durr, A; Holmans, P; Kilarski, LL; Guerreiro, R; Hernandez, DG; Brice, A; Ylikotila, P; Stefánsson, H; Majamaa, K; Morris, HR; Williams, N; Gasser, T; Heutink, P; Wood, NW; Hardy, J; Martinez, M; Singleton, AB; Nalls, MA; International Parkinson's Disease Genomics Consortium (IPDGC); Wellcome Trust Case Control Consortium 2 (WTCCC2) (2012) Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease. Human Molecular Genetics, 21 (22). 4996 - 5009. https://doi.org/10.1093/hmg/dds335
SGUL Authors: Kilarski, Laura Luisa

Full text not available from this repository.

Abstract

Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17-38, P = 8.08E - 08) phenotypic variance associated with all types of PD, 15% (95% CI -0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17-44, P = 1.34E - 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.

Item Type: Article
Additional Information: PMCID: PMC3576713
Keywords: Adult, Aged, Aged, 80 and over, European Continental Ancestry Group, Female, Genetic Predisposition to Disease, Genetic Variation, Genome-Wide Association Study, Humans, Male, Middle Aged, Multifactorial Inheritance, Parkinson Disease, Quantitative Trait, Heritable
Journal or Publication Title: Human Molecular Genetics
Related URLs:
Dates:
DateEvent
15 November 2012Published
PubMed ID: 22892372
Web of Science ID: 22892372
Download EPMC Full text (PDF)
Download EPMC Full text (HTML)
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/103515
Publisher's version: https://doi.org/10.1093/hmg/dds335

Actions (login required)

Edit Item Edit Item